These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 38694127)

  • 41. Effects of long non-coding RNA Opa-interacting protein 5 antisense RNA 1 on colon cancer cell resistance to oxaliplatin and its regulation of microRNA-137.
    Liang J; Tian XF; Yang W
    World J Gastroenterol; 2020 Apr; 26(13):1474-1489. PubMed ID: 32308348
    [TBL] [Abstract][Full Text] [Related]  

  • 42. SMYD2-OE promotes oxaliplatin resistance in colon cancer through MDR1/P-glycoprotein via MEK/ERK/AP1 pathway.
    Ren H; Wang Z; Chen Y; Liu Y; Zhang S; Zhang T; Li Y
    Onco Targets Ther; 2019; 12():2585-2594. PubMed ID: 31040701
    [TBL] [Abstract][Full Text] [Related]  

  • 43. CircAGFG1 absence decreases PKM2 expression to enhance oxaliplatin sensitivity in colorectal cancer in a miR-7-5p-dependent manner.
    Chen J; Wang H; Tang M
    J Chemother; 2024 May; 36(3):208-221. PubMed ID: 37691430
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Construction of TRAF6 ubiquitin site 331 mutant colorectal cancer cell stable line and its effect on biological behavior of colorectal cancer cells].
    He RF; Wang Q; Lin CL; Lin PH; Chen H; Huang YJ; Yang SG; Ye JX; Zhu GW
    Zhonghua Zhong Liu Za Zhi; 2023 Feb; 45(2):129-137. PubMed ID: 36781233
    [No Abstract]   [Full Text] [Related]  

  • 45. DUSP4 inhibits autophagic cell death and apoptosis in colorectal cancer by regulating BCL2-Beclin1/Bax signaling.
    Xu W; Nie C; Chen X
    Mol Biol Rep; 2023 Apr; 50(4):3229-3239. PubMed ID: 36705792
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Role of AMPK in Regulation of Oxaliplatin-Resistant Human Colorectal Cancer.
    Park SY; Chung YS; Park SY; Kim SH
    Biomedicines; 2022 Oct; 10(11):. PubMed ID: 36359211
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Different effects of epigenetic modifiers on the cytotoxicity induced by 5-fluorouracil, irinotecan or oxaliplatin in colon cancer cells.
    Ikehata M; Ogawa M; Yamada Y; Tanaka S; Ueda K; Iwakawa S
    Biol Pharm Bull; 2014; 37(1):67-73. PubMed ID: 24172061
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Role of HOXB7 in promoting gastric cancer progression and oxaliplatin (L-OHP) resistance.
    Yuan C; Xie Y; Sheng X; Xie X; Liu J; Zeng S; Wang X
    Int J Clin Exp Pathol; 2020; 13(6):1381-1389. PubMed ID: 32661473
    [TBL] [Abstract][Full Text] [Related]  

  • 49. LncRNA NEAT1 knockdown attenuates autophagy to elevate 5-FU sensitivity in colorectal cancer via targeting miR-34a.
    Liu F; Ai FY; Zhang DC; Tian L; Yang ZY; Liu SJ
    Cancer Med; 2020 Feb; 9(3):1079-1091. PubMed ID: 31802650
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Knockdown of ADAM17 inhibits cell proliferation and increases oxaliplatin sensitivity in HCT-8 colorectal cancer through EGFR-PI3K-AKT activation.
    Zhang Q; Wang C; Han X; Yang G; Ge Z; Zhang G
    Biochem Biophys Res Commun; 2018 Sep; 503(4):2333-2339. PubMed ID: 29964008
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dihydroartemisinin inhibited stem cell-like properties and enhanced oxaliplatin sensitivity of colorectal cancer via AKT/mTOR signaling.
    Wang Y; Yang Z; Zhu W; Chen Y; He X; Li J; Han Z; Yang Y; Liu W; Zhang K
    Drug Dev Res; 2023 Aug; 84(5):988-998. PubMed ID: 37132439
    [TBL] [Abstract][Full Text] [Related]  

  • 52. miR-122 Targets X-Linked Inhibitor of Apoptosis Protein to Sensitize Oxaliplatin-Resistant Colorectal Cancer Cells to Oxaliplatin-Mediated Cytotoxicity.
    Hua Y; Zhu Y; Zhang J; Zhu Z; Ning Z; Chen H; Liu L; Chen Z; Meng Z
    Cell Physiol Biochem; 2018; 51(5):2148-2159. PubMed ID: 30522111
    [TBL] [Abstract][Full Text] [Related]  

  • 53. S100A10 protein expression is associated with oxaliplatin sensitivity in human colorectal cancer cells.
    Suzuki S; Yamayoshi Y; Nishimuta A; Tanigawara Y
    Proteome Sci; 2011 Dec; 9():76. PubMed ID: 22206547
    [TBL] [Abstract][Full Text] [Related]  

  • 54. PKM2 Subcellular Localization Is Involved in Oxaliplatin Resistance Acquisition in HT29 Human Colorectal Cancer Cell Lines.
    Ginés A; Bystrup S; Ruiz de Porras V; Guardia C; Musulén E; Martínez-Cardús A; Manzano JL; Layos L; Abad A; Martínez-Balibrea E
    PLoS One; 2015; 10(5):e0123830. PubMed ID: 25955657
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Involvement of Met receptor pathway in aggressive behavior of colorectal cancer cells induced by parathyroid hormone-related peptide.
    Novoa Díaz MB; Carriere P; Gigola G; Zwenger AO; Calvo N; Gentili C
    World J Gastroenterol; 2022 Jul; 28(26):3177-3200. PubMed ID: 36051345
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Combined chemotherapy of hydroxycampothecin with oxaliplatin as an adjuvant treatment for human colorectal cancer.
    Yao Y; Zhao H; Sun Y; Lin F; Tang L; Chen P
    Tohoku J Exp Med; 2008 Jul; 215(3):267-78. PubMed ID: 18648187
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prostaglandin F
    Wang YJ; Xie XL; Liu HQ; Tian H; Jiang XY; Zhang JN; Chen SX; Liu T; Wang SL; Zhou X; Jin XX; Liu SM; Jiang HQ
    World J Gastroenterol; 2023 Oct; 29(39):5452-5470. PubMed ID: 37900995
    [TBL] [Abstract][Full Text] [Related]  

  • 58. GDPD5, a target of miR-195-5p, is associated with metastasis and chemoresistance in colorectal cancer.
    Feng C; Zhang L; Sun Y; Li X; Zhan L; Lou Y; Wang Y; Liu L; Zhang Y
    Biomed Pharmacother; 2018 May; 101():945-952. PubMed ID: 29635904
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Establishment and biological characteristics of oxaliplatin-resistant human colon cancer cell lines.
    Liu Z; Qiu M; Tang QL; Liu M; Lang N; Bi F
    Chin J Cancer; 2010 Jul; 29(7):661-7. PubMed ID: 20591218
    [TBL] [Abstract][Full Text] [Related]  

  • 60. ASPP2 enhances oxaliplatin (L-OHP)-induced colorectal cancer cell apoptosis in a p53-independent manner by inhibiting cell autophagy.
    Shi Y; Han Y; Xie F; Wang A; Feng X; Li N; Guo H; Chen D
    J Cell Mol Med; 2015 Mar; 19(3):535-43. PubMed ID: 25534115
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.